Cite
HARVARD Citation
Fox, E. et al. (2018). 033 Effect of ocrelizumab on upper limb function in patients with primary progressive multiple sclerosis (PPMS) in the oratorio study (ENCORE). Journal of neurology, neurosurgery and psychiatry. 89 (6), p. A14. [Online].